Rocket Pharmaceuticals, Inc.
- RCKT
- NASDAQ
- Biotechnology
- Gene Therapy (Rare Diseases)
- Clinical-Stage Biotech
$2.18
Today −7.63%Quote Oct 16, 2026, 08:00 PM UTC
−37.71%over the last month
Max drawdown −37.7%From 1-month high −37.7%3 months −36.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$239.3M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$5.32
+144.0% from here
Floor
$2.03
6.7% below price
Where the price sits
19 analysts
Analyst range, low to high
$2.95$9.00
- Price $2.18
- Resistance $2.18
- Consensus $5.32
Analysts' average target sits about 144% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RCKTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
202